CRDF icon

Cardiff Oncology
CRDF

Overview Fund Activity

90 hedge funds and large institutions have $29.1M invested in Cardiff Oncology in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 12 reducing their positions, and 16 closing their positions.

Holders
90
Holders Change
+13
Holders Change %
+16.88%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
33
Reduced
12
Closed
16
Calls
$1.86M
Puts
$238K
Net Calls
+$1.63M
Net Calls Change
-$2.71M

Top Buyers

1
BlackRock
1
BlackRock
New York
$5.84M
2
Assenagon Asset Management
2
Assenagon Asset Management
Luxembourg
$2.7M
3
State Street
3
State Street
Massachusetts
$1.79M
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$2.02M
5
Morgan Stanley
5
Morgan Stanley
New York
$1.14M

Top Sellers

1
LCM
1
Laurion Capital Management
New York
$0
2
Millennium Management
2
Millennium Management
New York
$532K
3
EI
3
EAM Investors
California
$0
4
HF
4
HRT Financial
New York
$0
5
Marshall Wace
5
Marshall Wace
United Kingdom
$663K
Name Holding Trade Value Shares
Change 		Shares
Change %
AI
101
Atom Investors
Texas
– -$81.7K -15,298 Closed
LP
102
LMR Partners
United Kingdom
– -$70K -13,101 Closed
CAS
103
CTC Alternative Strategies
Illinois
– -$66.2K -12,400 Closed
Connor, Clark & Lunn Investment Management (CC&L)
104
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$54K -10,105 Closed
Macquarie Group
105
Macquarie Group
Australia
– -$7 -1,368 Closed
NFSG
106
Newbridge Financial Services Group
Florida
– -$91 -17 Closed
1 2 3 4
5